Shortage reports
Actual shortage:
65 (10%)
Anticipated shortage:
15 (2%)
Avoided shortage:
16 (2%)
Resolved:
570 (86%)
666
Discontinuation Reports
To be discontinued:
7 (10%)
Discontinued:
54 (75%)
Reversed:
11 (15%)
72
52 (7%)
17 (20%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-10-10 | 2017-10-27 | 24913 |
| GABAPENTIN | 800MG | TABLET | Actual shortage | 2024-07-03 | 2024-12-02 | 232020 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2024-01-30 | 2024-03-14 | 217766 |
| GABAPENTIN | 100MG | CAPSULE | Anticipated shortage | 2026-03-30 | 2026-03-30 | 281855 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2024-05-28 | 2024-10-08 | 228997 |
| GABAPENTIN | 800MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114766 |
| GABAPENTIN | 600MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114770 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-07-08 | 2021-02-10 | 119747 |
| GALANTAMINE ER | 16MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-10-23 | 2024-04-04 | 207850 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-07-31 | 2024-01-30 | 200443 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2025-04-01 | 2025-06-14 | 253778 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-02-13 | 2024-04-04 | 219378 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-05-11 | 2021-02-10 | 114761 |
| GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-11-01 | 2026-01-06 | 241793 |
| GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-26 | 2024-05-29 | 223456 |
| GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-26 | 2026-01-06 | 223453 |
| HYDROCHLOROTHIAZIDE | 50MG | TABLET | Actual shortage | 2024-06-06 | 2024-06-06 | 229804 |
| IMATINIB | 100MG | TABLET | Resolved | 2024-04-19 | 2025-11-04 | 225711 |
| IMATINIB | 400MG | TABLET | Resolved | 2024-04-19 | 2025-11-04 | 225714 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2024-11-25 | 2025-12-09 | 243736 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107364 | ||
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2412 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
| FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| INDAPAMIDE | 1.25MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2453 |